Generic drugmaker says it agreed to contribute sum in cash and medications to states, local governments and tribes for its role in epidemic

American Jews have not been spared the devastating fallout of opioid abuse, which claimed 107,000 US lives in 2021, though some still struggle with stigmas while seeking help

Affiliate of Israel pharmaceutical giant says settling federal lawsuit is a step toward getting life-saving treatment to addicts, but doesn't admit liability or wrongdoing

In latest settlement, like past ones, US subsidiary of Israeli generic drugmaker to provide over $84m worth of treatment medicines

Move follows global outrage over family's role in the opioid crisis

Agreement will see US subsidiary of Israeli generic drugmaker also provide over $78m worth of treatments that aid in addiction treatment and prevention

Some criticize settlement, which leaves amount to go to victims of addictive OxyContin unchanged while shielding family from further attempts to make them pay for crisis

Agreement with US subsidiary of Israeli pharmaceutical giant also includes $75m provision of generic medicine doses that aid in opioid addiction and recovery

Pharma giant says it plans to appeal after court says firm was 'deceptive' in marketing two cancer drugs containing fentanyl for other types of pain

Company says its generic version of Narcan is the first to arrive in markets; firm faces multiple legal challenges for allegedly stoking opioid epidemic